Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats

Epirubicin is a chemotherapy agent for hepatocellular carcinoma (HCC). However, the outcome of HCC patients receiving epirubicin remains unsatisfactory. Moreover, our previous study indicated that celecoxib suppresses HCC progression and liver cancer stemness. This study evaluated the potential of c...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Med
Главные авторы: Chu, Tian‐Huei, Chan, Hoi‐Hung, Hu, Tsung‐Hui, Wang, E‐Ming, Ma, Yi‐Ling, Huang, Shih‐Chung, Wu, Jian‐Ching, Chang, Yi‐Chen, Weng, Wen‐Tsan, Wen, Zhi‐Hong, Wu, Deng‐Chyang, Chen, Yi‐Ming Arthur, Tai, Ming‐Hong
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Cancer Biology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010827/
https://ncbi.nlm.nih.gov/pubmed/29683262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1487
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы